nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—Death Receptor Signalling—TNFRSF10B—head and neck cancer	0.0561	0.0561	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.046	0.046	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—CSF3—head and neck cancer	0.0378	0.0378	CbGpPWpGaD
Amrinone—TNF—Matrix Metalloproteinases—MMP8—head and neck cancer	0.0328	0.0328	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.0313	0.0313	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNFRSF10B—head and neck cancer	0.0193	0.0193	CbGpPWpGaD
Amrinone—TNF—Death Receptor Signalling—CASP8—head and neck cancer	0.0192	0.0192	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—TNFRSF10B—head and neck cancer	0.0182	0.0182	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—CEBPA—head and neck cancer	0.0169	0.0169	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TNFRSF10B—head and neck cancer	0.0134	0.0134	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—BCL2—head and neck cancer	0.0129	0.0129	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.0122	0.0122	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—GPX1—head and neck cancer	0.0119	0.0119	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—CEBPA—head and neck cancer	0.0111	0.0111	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—BCL2L1—head and neck cancer	0.0105	0.0105	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.0101	0.0101	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.0101	0.0101	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.01	0.01	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00989	0.00989	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP8—head and neck cancer	0.00965	0.00965	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—STAT6—head and neck cancer	0.00887	0.00887	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL2—head and neck cancer	0.00882	0.00882	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL2—head and neck cancer	0.00856	0.00856	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—BCL2—head and neck cancer	0.00828	0.00828	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TNFRSF10B—head and neck cancer	0.0082	0.0082	CbGpPWpGaD
Amrinone—TNF—Cellular roles of Anthrax toxin—MAPK3—head and neck cancer	0.00811	0.00811	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—SOD2—head and neck cancer	0.00805	0.00805	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—CASP8—head and neck cancer	0.00796	0.00796	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—CASP8—head and neck cancer	0.00796	0.00796	CbGpPWpGaD
Amrinone—TNF—Cellular roles of Anthrax toxin—MAPK1—head and neck cancer	0.00772	0.00772	CbGpPWpGaD
Amrinone—TNF—Type II diabetes mellitus—MAPK1—head and neck cancer	0.00772	0.00772	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—GPX1—head and neck cancer	0.00768	0.00768	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—BCL2L1—head and neck cancer	0.00762	0.00762	CbGpPWpGaD
Amrinone—TNF—EBV LMP1 signaling—MAPK1—head and neck cancer	0.00745	0.00745	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—STAT3—head and neck cancer	0.00743	0.00743	CbGpPWpGaD
Amrinone—TNF—TNF receptor signaling pathway —CASP8—head and neck cancer	0.0074	0.0074	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—BCL2—head and neck cancer	0.0074	0.0074	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—CASP8—head and neck cancer	0.00715	0.00715	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—BCL2—head and neck cancer	0.00683	0.00683	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL2—head and neck cancer	0.00665	0.00665	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00639	0.00639	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00634	0.00634	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—CASP8—head and neck cancer	0.00623	0.00623	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—BCL2—head and neck cancer	0.00614	0.00614	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—GPX1—head and neck cancer	0.0061	0.0061	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00603	0.00603	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00577	0.00577	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—head and neck cancer	0.00564	0.00564	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—STAT3—head and neck cancer	0.0056	0.0056	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2L1—head and neck cancer	0.00559	0.00559	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00559	0.00559	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—BCL2—head and neck cancer	0.00535	0.00535	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.00523	0.00523	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—BCL2L1—head and neck cancer	0.0052	0.0052	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—MAPK3—head and neck cancer	0.00483	0.00483	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—CASP8—head and neck cancer	0.0048	0.0048	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—CASP8—head and neck cancer	0.0048	0.0048	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00475	0.00475	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—MAPK1—head and neck cancer	0.0046	0.0046	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP8—head and neck cancer	0.00457	0.00457	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—PIK3CA—head and neck cancer	0.00442	0.00442	CbGpPWpGaD
Amrinone—PDE4B—Opioid Signalling—MAPK1—head and neck cancer	0.00439	0.00439	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—MAPK3—head and neck cancer	0.00434	0.00434	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00428	0.00428	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00428	0.00428	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00428	0.00428	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—CASP8—head and neck cancer	0.00425	0.00425	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—MAPK3—head and neck cancer	0.0042	0.0042	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—IL2—head and neck cancer	0.00419	0.00419	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IL2—head and neck cancer	0.00419	0.00419	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—head and neck cancer	0.00418	0.00418	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—STAT3—head and neck cancer	0.00414	0.00414	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—MAPK1—head and neck cancer	0.00413	0.00413	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—KISS1—head and neck cancer	0.00401	0.00401	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—MAPK1—head and neck cancer	0.004	0.004	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—MAPK3—head and neck cancer	0.00395	0.00395	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2—head and neck cancer	0.00392	0.00392	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—CASP8—head and neck cancer	0.00391	0.00391	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—MAPK3—head and neck cancer	0.0039	0.0039	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—MAPK1—head and neck cancer	0.00382	0.00382	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—KISS1—head and neck cancer	0.00382	0.00382	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CEBPA—head and neck cancer	0.00381	0.00381	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—MAPK1—head and neck cancer	0.00371	0.00371	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—KISS1—head and neck cancer	0.00364	0.00364	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL2—head and neck cancer	0.00363	0.00363	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00359	0.00359	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.00347	0.00347	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00347	0.00347	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—KISS1—head and neck cancer	0.00347	0.00347	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.00343	0.00343	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2L1—head and neck cancer	0.00343	0.00343	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—MAPK3—head and neck cancer	0.00337	0.00337	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—STAT3—head and neck cancer	0.00336	0.00336	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—GRP—head and neck cancer	0.0033	0.0033	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—AKT1—head and neck cancer	0.00326	0.00326	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—MAPK1—head and neck cancer	0.0032	0.0032	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—HRAS—head and neck cancer	0.00316	0.00316	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—GRP—head and neck cancer	0.00314	0.00314	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—VEGFA—head and neck cancer	0.00308	0.00308	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—CASP8—head and neck cancer	0.00305	0.00305	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—HRAS—head and neck cancer	0.00302	0.00302	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—GRP—head and neck cancer	0.003	0.003	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—AKT1—head and neck cancer	0.00293	0.00293	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—MAPK3—head and neck cancer	0.00292	0.00292	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—head and neck cancer	0.00291	0.00291	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—GRP—head and neck cancer	0.00285	0.00285	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—PTGS2—head and neck cancer	0.00284	0.00284	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.00284	0.00284	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP8—head and neck cancer	0.0028	0.0028	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK3—head and neck cancer	0.00278	0.00278	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—MAPK1—head and neck cancer	0.00277	0.00277	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CDH1—head and neck cancer	0.00277	0.00277	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—head and neck cancer	0.00271	0.00271	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—TP53—head and neck cancer	0.00269	0.00269	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK1—head and neck cancer	0.00264	0.00264	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IL2—head and neck cancer	0.00263	0.00263	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—AKT1—head and neck cancer	0.00263	0.00263	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—CASP8—head and neck cancer	0.00263	0.00263	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—MAPK3—head and neck cancer	0.00258	0.00258	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—head and neck cancer	0.00257	0.00257	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CCND1—head and neck cancer	0.00257	0.00257	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—AKT1—head and neck cancer	0.00255	0.00255	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—MAPK1—head and neck cancer	0.00246	0.00246	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2—head and neck cancer	0.0024	0.0024	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—MAPK3—head and neck cancer	0.00238	0.00238	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00237	0.00237	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—TP53—head and neck cancer	0.00233	0.00233	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—head and neck cancer	0.00229	0.00229	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—MAPK1—head and neck cancer	0.00226	0.00226	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—head and neck cancer	0.00222	0.00222	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—KISS1—head and neck cancer	0.00215	0.00215	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—MAPK3—head and neck cancer	0.00212	0.00212	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—STAT3—head and neck cancer	0.00205	0.00205	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—KISS1—head and neck cancer	0.00205	0.00205	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.00203	0.00203	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—MAPK1—head and neck cancer	0.00201	0.00201	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—EGFR—head and neck cancer	0.00201	0.00201	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—HRAS—head and neck cancer	0.00197	0.00197	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—head and neck cancer	0.00196	0.00196	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00193	0.00193	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—head and neck cancer	0.00187	0.00187	CbGpPWpGaD
Amrinone—TNF—Apoptosis—AKT1—head and neck cancer	0.00187	0.00187	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—MAPK3—head and neck cancer	0.00186	0.00186	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00179	0.00179	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—GRP—head and neck cancer	0.00177	0.00177	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—MAPK1—head and neck cancer	0.00177	0.00177	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.00174	0.00174	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—AKT1—head and neck cancer	0.00174	0.00174	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—STAT6—head and neck cancer	0.00172	0.00172	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TP53—head and neck cancer	0.00169	0.00169	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—GRP—head and neck cancer	0.00169	0.00169	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.00168	0.00168	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—STAT6—head and neck cancer	0.00164	0.00164	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	0.0016	0.0016	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—MAPK3—head and neck cancer	0.00159	0.00159	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	0.00153	0.00153	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—YAP1—head and neck cancer	0.00152	0.00152	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00152	0.00152	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—MAPK1—head and neck cancer	0.00152	0.00152	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—EGFR—head and neck cancer	0.00152	0.00152	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—YAP1—head and neck cancer	0.00145	0.00145	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.00144	0.00144	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—IL2—head and neck cancer	0.00139	0.00139	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00137	0.00137	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00137	0.00137	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—head and neck cancer	0.00136	0.00136	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TP53—head and neck cancer	0.00127	0.00127	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.00125	0.00125	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—NOTCH1—head and neck cancer	0.00122	0.00122	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.00119	0.00119	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—VEGFA—head and neck cancer	0.00118	0.00118	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.00115	0.00115	CbGpPWpGaD
Amrinone—TNF—Apoptosis—AKT1—head and neck cancer	0.00115	0.00115	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—MAPK3—head and neck cancer	0.00112	0.00112	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—AKT1—head and neck cancer	0.00108	0.00108	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—MAPK1—head and neck cancer	0.00107	0.00107	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000971	0.000971	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—PIK3CA—head and neck cancer	0.000925	0.000925	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TP53—head and neck cancer	0.000895	0.000895	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—IL2—head and neck cancer	0.00088	0.00088	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—HRAS—head and neck cancer	0.000855	0.000855	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—IL2—head and neck cancer	0.000837	0.000837	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—IL2—head and neck cancer	0.000799	0.000799	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—IL2—head and neck cancer	0.00076	0.00076	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—AKT1—head and neck cancer	0.000755	0.000755	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—VEGFA—head and neck cancer	0.000711	0.000711	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—STAT3—head and neck cancer	0.000704	0.000704	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NOTCH1—head and neck cancer	0.000686	0.000686	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—MAPK3—head and neck cancer	0.000673	0.000673	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NOTCH1—head and neck cancer	0.000653	0.000653	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—MAPK3—head and neck cancer	0.000643	0.000643	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—MAPK1—head and neck cancer	0.00064	0.00064	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—EGFR—head and neck cancer	0.00064	0.00064	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—MAPK1—head and neck cancer	0.000612	0.000612	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—EGFR—head and neck cancer	0.000611	0.000611	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—MAPK3—head and neck cancer	0.000611	0.000611	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000584	0.000584	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—MAPK1—head and neck cancer	0.000582	0.000582	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—EGFR—head and neck cancer	0.000582	0.000582	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000556	0.000556	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PIK3CA—head and neck cancer	0.000531	0.000531	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—HRAS—head and neck cancer	0.000514	0.000514	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PIK3CA—head and neck cancer	0.000505	0.000505	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—HRAS—head and neck cancer	0.000491	0.000491	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—AKT1—head and neck cancer	0.000477	0.000477	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IL2—head and neck cancer	0.000472	0.000472	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—HRAS—head and neck cancer	0.000467	0.000467	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CCND1—head and neck cancer	0.00046	0.00046	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—AKT1—head and neck cancer	0.000454	0.000454	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—AKT1—head and neck cancer	0.000454	0.000454	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IL2—head and neck cancer	0.000449	0.000449	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTEN—head and neck cancer	0.000444	0.000444	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CCND1—head and neck cancer	0.000438	0.000438	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—AKT1—head and neck cancer	0.000434	0.000434	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTEN—head and neck cancer	0.000423	0.000423	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—AKT1—head and neck cancer	0.000412	0.000412	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—VEGFA—head and neck cancer	0.000401	0.000401	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—STAT3—head and neck cancer	0.000397	0.000397	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—VEGFA—head and neck cancer	0.000382	0.000382	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MAPK3—head and neck cancer	0.00038	0.00038	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—STAT3—head and neck cancer	0.000378	0.000378	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MAPK1—head and neck cancer	0.000361	0.000361	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—EGFR—head and neck cancer	0.000361	0.000361	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MAPK3—head and neck cancer	0.000361	0.000361	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MAPK1—head and neck cancer	0.000344	0.000344	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—EGFR—head and neck cancer	0.000344	0.000344	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PIK3CA—head and neck cancer	0.000313	0.000313	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TP53—head and neck cancer	0.000303	0.000303	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PIK3CA—head and neck cancer	0.000298	0.000298	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—HRAS—head and neck cancer	0.00029	0.00029	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TP53—head and neck cancer	0.000288	0.000288	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—HRAS—head and neck cancer	0.000276	0.000276	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—AKT1—head and neck cancer	0.000256	0.000256	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—AKT1—head and neck cancer	0.000244	0.000244	CbGpPWpGaD
